Alps Advisors Inc Medpace Holdings, Inc. Transaction History

Alps Advisors Inc

$17.2 Billion
Q1 2025

A detailed history of Alps Advisors Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 1,098 shares of MEDP stock, worth $491,344. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,098

Previous 998 10.02%

Holding current value

$491,344

Previous $331,000 0.91%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$304.69 - $360.97 $30,469 - $36,097	100 Added 10.02%	1,098 $334,000
Q3 2024 Nov 12, 2024	BUY	$320.58 - $457.29 $44,881 - $64,020	140 Added 16.32%	998 $332,000
Q1 2024 May 14, 2024	SELL	$284.87 - $413.31 $82,327 - $119,446	-289 Reduced 25.2%	858 $346,000
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $14,788 - $20,324	-65 Reduced 5.36%	1,147 $351,000
Q3 2023 Nov 14, 2023	SELL	$233.98 - $281.67 $140,154 - $168,720	-599 Reduced 33.08%	1,212 $293,000
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $1,872 - $2,401	10 Added 0.56%	1,811 $434,000
Q1 2023 May 10, 2023	SELL	$174.31 - $239.52 $45,669 - $62,754	-262 Reduced 12.7%	1,801 $338,000
Q4 2022 Feb 14, 2023	SELL	$153.06 - $226.57 $765 - $1,132	-5 Reduced 0.24%	2,063 $438,000
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $300,128 - $377,389	2,068 New	2,068 $325,000
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $282,183 - $435,477	-2,032 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$182.74 - $227.9 $4,568 - $5,697	25 Added 1.25%	2,032 $442,000
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $13,274 - $15,460	-78 Reduced 3.74%	2,007 $380,000
Q1 2021 May 07, 2021	SELL	$132.02 - $168.26 $12,805 - $16,321	-97 Reduced 4.45%	2,085 $342,000
Q4 2020 Feb 03, 2021	SELL	$109.38 - $149.19 $7,219 - $9,846	-66 Reduced 2.94%	2,182 $304,000
Q3 2020 Nov 04, 2020	SELL	$92.95 - $130.61 $49,728 - $69,876	-535 Reduced 19.22%	2,248 $251,000
Q2 2020 Aug 05, 2020	SELL	$68.08 - $95.68 $21,036 - $29,565	-309 Reduced 9.99%	2,783 $259,000
Q1 2020 May 06, 2020	SELL	$61.71 - $101.95 $60,537 - $100,012	-981 Reduced 24.09%	3,092 $227,000
Q4 2019 Feb 07, 2020	SELL	$70.08 - $84.64 $12,404 - $14,981	-177 Reduced 4.16%	4,073 $342,000
Q3 2019 Nov 04, 2019	SELL	$62.38 - $85.89 $185,268 - $255,093	-2,970 Reduced 41.14%	4,250 $357,000
Q2 2019 Aug 07, 2019	SELL	$53.64 - $65.42 $20,383 - $24,859	-380 Reduced 5.0%	7,220 $472,000
Q1 2019 May 01, 2019	BUY	$49.38 - $70.58 $25,529 - $36,489	517 Added 7.3%	7,600 $448,000
Q4 2018 Feb 04, 2019	SELL	$46.97 - $63.98 $27,571 - $37,556	-587 Reduced 7.65%	7,083 $375,000
Q3 2018 Oct 25, 2018	BUY	$43.25 - $63.74 $331,727 - $488,885	7,670 New	7,670 $460,000

Others Institutions Holding MEDP

# of Institutions

632

Shares Held

25.7M

Call Options Held

47K

Put Options Held

80.8K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $13.9B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Medpace Holdings, Inc. Transaction History